Jagsonpal Pharmaceuticals Investor Relations Material
Latest events
Q2 24/25
Jagsonpal Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Jagsonpal Pharmaceuticals Limited
Access all reports
Jagsonpal Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of branded generic formulations. The company offers a range of dosage forms including tablets, capsules, syrups, and injectables across therapeutic segments such as gynecology, orthopedics, dermatology, and general medicine. It serves domestic and international markets through an established distribution network and field force. The company is headquartered in New Delhi, India, and its shares are listed on the BSE.
Key slides for Jagsonpal Pharmaceuticals Limited
Q3 24/25
Jagsonpal Pharmaceuticals Limited
Q3 24/25
Jagsonpal Pharmaceuticals Limited
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
JAGSNPHARM
Country
🇮🇳 India